Charles M. Alexander

6.1k total citations · 1 hit paper
72 papers, 3.9k citations indexed

About

Charles M. Alexander is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics. According to data from OpenAlex, Charles M. Alexander has authored 72 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Surgery and 20 papers in Economics and Econometrics. Recurrent topics in Charles M. Alexander's work include Diabetes Treatment and Management (23 papers), Lipoproteins and Cardiovascular Health (19 papers) and Diabetes Management and Research (18 papers). Charles M. Alexander is often cited by papers focused on Diabetes Treatment and Management (23 papers), Lipoproteins and Cardiovascular Health (19 papers) and Diabetes Management and Research (18 papers). Charles M. Alexander collaborates with scholars based in United States, Germany and Canada. Charles M. Alexander's co-authors include Pamela B. Landsman, Steven M. Teutsch, Steven M. Haffner, Cynthia J. Girman, Peter P. Stein, Ross J. Simpson, M. N. Cook, Tzuyung D. Kou, Edward A. O’Neill and Stephen J. Boccuzzi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Charles M. Alexander

70 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

2003 1.2k citations Charles M. Alexander, Pamela B. Landsman et al. profile →

Peers

Countries citing papers authored by Charles M. Alexander

Since Specialization

Citations

This map shows the geographic impact of Charles M. Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Alexander more than expected).

Fields of papers citing papers by Charles M. Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles M. Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Alexander. The network helps show where Charles M. Alexander may publish in the future.

Co-authorship network of co-authors of Charles M. Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of Charles M. Alexander. A scholar is included among the top collaborators of Charles M. Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles M. Alexander. Charles M. Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes 2012 ·BMC Endocrine Disorders ·Alan J. Sinclair, Charles M. Alexander, Michael J. Davies, (unknown), Panagiotis Mavros	25
2	Risk of acute renal failure in patients with Type 2 diabetes mellitus 2011 ·Diabetic Medicine ·Cynthia J. Girman, Tzuyung D. Kou, Kimberly G. Brodovicz, Charles M. Alexander, Edward A. O’Neill, Samuel S. Engel, Debora Williams‐Herman, Leonid Katz	67
3	Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes 2010 ·Diabetes Obesity and Metabolism ·Cynthia J. Girman, Tzuyung D. Kou, (unknown), Charles M. Alexander, Edward A. O’Neill, Debora Williams‐Herman, Leonid Katz	161
4	Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims 2009 ·Clinical Therapeutics ·Colleen A. McHorney, C. Victor Spain, Charles M. Alexander, (unknown)	46
5	Patient‐reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain 2009 ·Diabetes Obesity and Metabolism ·Elizabeth Marrett, Tom Stargardt, Panagiotis Mavros, Charles M. Alexander	64
6	Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes 2009 ·Health and Quality of Life Outcomes ·Tom Stargardt, Linda Gonder‐Frederick, Karl J. Krobot, Charles M. Alexander	54
7	Contemporary Analysis of Secondary Failure of Successful Sulfonylurea Therapy 2007 ·Endocrine Practice ·Gregory A. Nichols, Charles M. Alexander, Cynthia J. Girman, Sachin Kamal‐Bahl, Jonathan B. Brown	18
8	The influence of age and body mass index on the metabolic syndrome and its components 2007 ·Diabetes Obesity and Metabolism ·Charles M. Alexander, Pamela B. Landsman, Scott M. Grundy	61
9	Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care 2007 ·Diabetic Medicine ·M. N. Cook, Cynthia J. Girman, Peter P. Stein, Charles M. Alexander	155
10	Metabolic Syndrome and Hyperglycemia: Congruence and Divergence 2006 ·The American Journal of Cardiology ·Charles M. Alexander, Pamela B. Landsman, Scott M. Grundy	34
11	Trends in Lipid Management Among Patients with Diabetes 2006 ·Endocrine Practice ·Kaan Tunceli, Manel Pladevall, L. Keoki Williams, George Divine, (unknown), (unknown), Shiva G. Sajjan, Sachin Kamal‐Bahl, Charles M. Alexander, Jennifer Elston Lafata	3
12	Reassessment of cardiovascular risk in diabetes 2006 ·Current Opinion in Lipidology ·(unknown), (unknown), Pamela B. Landsman, Charles M. Alexander	9
13	Disparities in lipid management for African Americans and Caucasians with coronary artery disease: A national cross-sectional study 2004 ·BMC Cardiovascular Disorders ·Mark W. Massing, Kathleen A. Foley, Lori Carter‐Edwards, Carla A. Sueta, Charles M. Alexander, Ross J. Simpson	25
14	Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy 2004 ·Kidney International ·Charles M. Alexander, Paulette A. Lyle, William F. Keane, George W. Carides, Zhongxin Zhang, Shahnaz Shahinfar	12
15	Population implications of changes in lipid management in patients with coronary heart disease 2004 ·The American Journal of Cardiology ·Kathleen A. Foley, Mark W. Massing, Ross J. Simpson, Charles M. Alexander, Leona E. Markson	12
16	Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor 2003 ·The American Journal of Medicine ·Steven A. Grover, Louis Coupal, Hanna Zowall, Thomas W. Weiss, Charles M. Alexander	6
17	Improved Cholesterol Management in Coronary Heart Disease Patients Enrolled in an HMO 2001 ·Journal for Healthcare Quality ·(unknown), George J. Wan, O. Niedermaier, (unknown), (unknown), (unknown), Charles M. Alexander	10
18	Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease 2000 ·The American Journal of Cardiology ·Charles M. Alexander, Pamela B. Landsman, Steven M. Teutsch	103
19	Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) 2000 ·The American Journal of Cardiology ·Antonio M. Gotto, Stephen J. Boccuzzi, J.R. Cook, Charles M. Alexander, (unknown), Gregg S. Meyer, Michael Clearfield, Stephen E. Weis, Edwin J. Whitney	27
20	Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease 1999 ·The American Journal of Cardiology ·Carla A. Sueta, Mridul Chowdhury, Stephen J. Boccuzzi, Sidney C. Smith, Charles M. Alexander, Anil Londhe, (unknown), Ross J. Simpson	225

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact